Florida’s Mount Sinai medical centre is using artificial intelligence (AI) to treat complex aortic conditions at the area’s only aortic centre.

The centre has implemented AI software designed to support the treatment of patients with complex aortic disease. As part of a collaboration between Cydar Medical and Medtronic, this software employs minimally invasive endovascular technology that is being used by surgeons at the aortic centre. It is the first and only institution to use this technology in all of eastern Florida.

The product integrates Cydar Maps software with Medtronic services and case support to improve patient care and efficiency with AI-based technology in a clinical environment.

Cydar’s platform generates a 3D map of the patient’s vascular system as well as supporting and integrating preoperative planning, intraoperative guidance and postoperative reviews of endovascular surgery. The platform uses AI to update the map throughout the patient’s journey, guaranteeing surgeries are completed with precision and success. The benefits include significantly decreased radiation exposure, simplified workflows and increased clinician confidence.

“The thing we are most excited about in the aortic centre is our incorporation of an AI image-based guidance programme that allows us to decrease radiation use on patients and decrease contrast or dye usage, which decreases the risk of problems with kidney function after these procedures, and allows us to perform these procedures in a more expedient manner,” said Micheal Ayad, co-director of the aortic centre. “It’s very exciting to be at the forefront of what’s considered the future of aortic surgery.”

UK-based Cydar developed its mapping platform to transform how information is shared with clinicians in image-guided minimally invasive surgery. The company designed it to simplify complexities within operating theatres across the globe.

The aortic centre uses a collaborative approach between cardiac surgeons, vascular surgeons, cardiologists and geneticists by coming together to address complex disease processes that otherwise would be very difficult to manage individually. This multidisciplinary approach allows for custom-made methods for various aortic and endovascular conditions.

“When you have a collaboration of different specialists, you are not getting a one-size-fits-all therapy but rather a custom-made approach,” said Ayad. “If we’ve learned anything over the past 20 to 30 years, it’s that not all patients’ diseases are the same. Each patient has a specific kind of aneurysm or a specific kind of disease, so a tailored approach provides a better outcome and a more durable outcome.”

Paul Mussenden, CEO of Cydar Medical, added: “We are thrilled a medical centre as renowned and respected as Mount Sinai has implemented our product into their clinical work. The goal is to provide their surgeons with a more predictable and efficient way to perform minimally invasive, image-guided procedures, leading to optimal results for their patients.”

Founded in 1949, the Mount Sinai medical centre (www.msmc.com) is the largest independent, private, not-for-profit teaching hospital in south Florida.

Cydar Medical is a cloud-based software company that provides an integrated product for planning, navigation and review of minimally invasive image guided surgical procedures. Cydar Maps uses AI to augment a clinician’s decision-making. The product harnesses computer vision and machine learning to advance surgical visualisation and decision-making in theatre, and across the surgical pathway. The AI continues to learn from procedures conducted globally to provide analytics to assist clinicians in the operating room, enabling them to make faster, easier and safer decisions in the future.

Cydar Medical (www.cydarmedical.com) is headquartered in Cambridge, UK, and has operations in the USA.